Skip to main content

Table 4 Characteristics of the complete cycles

From: Recombinant LH supplementation improves cumulative live birth rates in the GnRH antagonist protocol: a multicenter retrospective study using a propensity score-matching analysis

Variables

r-FSH/r-LH

r-FSH

p

No. of cycles

702

2106

 

Female age (year)

30.56 ± 5.22

30.55 ± 4.65

0.940

Male age (year)

32.43 ± 6.12

32.37 ± 5.17

0.826

Female BMI (kg/m2)

22.55 ± 3.00

22.55 ± 3.28

0.989

Infertility factor, n (%)

  

0.946

 Ovulatory disorder

184 (26.21%)

561 (26.64%)

 

 Diminished ovary reserve

80 (11.40%)

258 (12.25%)

 

 Pelvic and tubal disease

267 (38.03%)

798 (37.89%)

 

 Endometriosis

50 (7.12%)

137 (6.51%)

 

 Male factor

121 (17.24%)

352 (16.71%)

 

Infertility type, n (%)

  

0.895

 Primary infertility

405 (57.69%)

1221 (57.98%)

 

 Secondary infertility

297 (42.31%)

885 (42.02%)

 

Basal FSH (IU/L)

6.54 (5.50,7.69)

6.36 (5.40,7.65)

0.187

Basal LH (IU/L)

4.92 (3.50, 6.79)

5.20 (3.68, 7.44)

0.006

AFC

18.00 (12.00,20.00)

17.00 (9.00,24.00)

0.514

Fertilization type, n (%)

  

0.612

 IVF

461 (65.67%)

1405 (66.71%)

 

 ICSI

241 (34.33%)

701 (33.29%)

 

E2 on trigger Day (pg/ml)

3613.00 (2069.50, 5111.00)

3084.00 (1832.00, 5336.00)

0.005

LH on trigger Day (IU/L)

2.60 (1.68, 3.84)

2.41 (1.40, 4.14)

0.021

P on trigger Day (ng/ml)

1.93 (0.80, 3.88)

1.03 (0.66, 1.73)

 < 0.001

Follicle counts on trigger Day

16.00 (11.00, 21.00)

14.00 (9.00, 20.00)

 < 0.001

  1. Data are displayed as mean ± standard deviation and median (interquartile range) for continuous variables and n (%) for categorical variables
  2. BMI body mass index, r-FSH recombinant follicle-stimulating hormone, r-LH recombinant luteinizing hormone, AFC antral follicle count, IVF in-vitro fertilization, ICSI intracytoplasmic sperm injection, E2 estradiol, P progestin